Leo did a conference call last year, and there wasn't anything particularly new then.

It's possible he's just going to amplify more on the clinical trial results. It could be that he's going to talk about Kevetrin more than what we know from the recent poster session.

Or it's possible there may be some news.

I'm not going to get all excited about this, because that's what the bashers want -- they want people saying "oh this must be some great news" so then if there ISN'T something new, they can use it to bash Leo and the stock.

I'm just completely confident that within months there's going to be some genuine big news that sends the stock price way, way up.